Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: A 6-month follow-up - The SOLO study

Acta Ophthalmologica

Volumn 91, Issue 5, 2013, Pages

  Bezatis, Athanasios ^a   Spital, Georg ^b   Höhn, Fabian ^c   Maier, Mathias ^d   Clemens, Christoph R ^e   Wachtlin, Joachim ^f   Lehmann, Florian ^g   Hattenbach, Lars Olof ^c   Feltgen, Nicolas ^h   Meyer, Carsten H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c KLINIKUM LUDWIGSHAFEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f St Gertrauden Hospital Berlin   (Germany)

^g UNIVERSITY OF REGENSBURG   (Germany)

^h UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

branch retinal vein occlusion; central retinal vein occlusion; dexamethasone; intravitreal injection; Ozurdex; slow release drug

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG IMPLANT; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETREATMENT; SLIT LAMP; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84880256116     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12020     Document Type: Article

References (24)

1. Bertelmann T, Kičová N, Messerschmidt-Roth A, Irle S, Sekundo W, &, Mennel S, (2011): The vitreomacular interface in retinal vein occlusion. Acta Ophthalmol 89: 327-331.
2. Branch Vein Occlusion Study Group (1986): Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol 104: 34-41.
3. Brown DM, Campochiaro PA, Singh RP, et al., (2010): Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117: 1124-1133.
4. Callizo J, Kroll P, Mennel S, et al., (2009): Radial optic neurotomy for central retinal vein occlusion: long-term retinal perfusion outcome. Ophthalmologica 223: 313-319.
5. Campochiaro PA, Heier JS, Feiner L, et al., (2010): Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117: 1102-1112.
6. Chan A, Leung LS, &, Blumenkranz MS, (2011): Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion. Clin Ophthalmol 5: 1043-1049.
7. Feltgen N, Pielen A, Hansen L, Bertram B, Agostini H, Jaissle GB, Hoerauf H, &, Stahl A, (2010): Intravitreal drug therapy for retinal vein occlusion -pathophysiological mechanisms and routinely used drugs. Klin Monbl Augenheilkd 227: 681-693.
8. Haller JA, Bandello F, Belfort R Jr, et al., (2010): Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117: 1134-1146.
9. Helb HM, Charbel Issa P, Fleckenstein M, Schmitz-Valckenberg S, Scholl HP, Eter N, &, Holz FG, (2010): Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol 88: 842-849.
10. Higashiyama T, Sawada O, Kakinoki M, Sawada T, Kawamura H, &, Ohji M, (2011): Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. Acta Ophthalmol [EPub ahead of print].
11. Jaissle GB, Szurman P, Feltgen N, et al., (2010): Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 249: 183-192.
12. Klein R, Moss SE, Meuer SM, &, Klein BE, (2008): The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 126: 513-518.
13. Koss MJ, Naser H, Sener A, Ackermann H, Al-Sarireh F, Singh P, &, Koch FH, (2010): Combination therapy in diabetic macular oedema and retinal vein occlusion-past and present. Acta Ophthalmol 90: 580-589.
14. Meyer CH, Michels S, Rodrigues EB, Hager A, Mennel S, Schmidt JC, Helb HM, &, Farah ME, (2011): Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections. Acta Ophthalmol 89: 70-75.
15. Meyer CH, Klein A, Alten F, Liu Z, Stanzel BV, Brinkmann CK, &, Helb HM, (2012): Release and velocity of micronized dexamethasone intravitreal implants with an intravitreal drug delivery system-kinematic analysis with a high-speed camera. Retina 32: 2133-2140.
16. Mirshahi A, Lorenz K, Kramann C, Stoffelns B, &, Hattenbach LO, (2011): phthalmologic diagnostic procedures and imaging of retinal vein occlusions. Ophthalmologe 108: 111-116.
17. Parodi MB, Iacono P, Cascavilla M, Zucchiatti I, &, Bandello F, (2012): Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting. Acta Ophthalmol 90: e322-e323.
18. Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, &, Soubrane G, (2012): Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes. Acta Ophthalmol 90: 357-361.
19. Ritch R, Prata TS, de Moraes CG, Vessani RM, Costa VP, Konstas AG, Liebmann JM, &, Schlötzer-Schrehardt U, (2010): Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis. Acta Ophthalmol 88: 91-95.
20. Rodrigues EB, Grumann A, Penha FM, et al., (2011): Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. J Ocul Pharmacol Ther 27: 197-203.
21. Rogers S, McIntosh RL, Cheung N, et al., (2010): The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117: 313-319.
22. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M, & SCORE Study Investigator Group: SCORE Study report 1 (2009a): Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 116: 504-512.
23. Scott IU, Ip MS, VanVeldhuisen PC, et al., (2009b): A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 127: 1115-1128.
24. Stefánsson E, (2001): The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79: 435-440.